Understanding Pomalyst® (pomalidomide) capsules

Pomalyst® (pomalidomide) is an immunomodulatory drug that is used only for patients with relapsed and refractory myeloma who have received at least two prior therapies, including Revlimid® (lenalidomide) and Velcade® (bortezomib), and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.